Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Edwards joins Ardena after 16 years at Catalent.
March 2, 2026
By: Patrick Lavery
Content Marketing Editor
Ardena has appointed Paul Edwards as its new Chief People Officer (CPO). Edwards comes to Ardena following 16 years at Catalent Pharma Solutions, where he was most recently Vice President, Human Resources.
Edwards’ appointment adds to two other personnel moves Ardena announced in late 2025. In November, the company named Dipesh Patel Chief Quality Officer and Peter Rose Chief Information Officer.
Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO, says Edwards will lead the company’s “global people strategy.”
More specifically, he will be tasked with strengthening capabilities both organization-wide and in a leadership context. Growing Ardena internationally, the company says, involves building a high-performance culture and ensuring support for productivity, speed, and scalability.
Ardena will ask Edwards to clarify accountability and develop talent and engagement frameworks, using his experience leading international HR teams.
Ardena CEO Jeremie Trochu said Edwards will play a “key role” in evolving the company in line with strategic ambitions.
“His track record leading global HR organizations within the biopharma services sector makes him a very strong addition,” Trochu said. “As Ardena continues to expand its capabilities and footprint internationally, investing in our people, leadership and culture is essential.”
“Ardena has a clear strategy and very strong scientific and technical foundations,” Edwards said. “I look forward to working with my new colleagues across the organization to further develop our leadership capability.”
Earlier in 2026, Ardena completed the divestment of its active pharmaceutical ingredient (API) site in Södertälje, Sweden, to Nanologica AB.
Ardena said at the time it would continue supporting customers with its integrated development approach. Prior to the deal, Ardena and Nanologica shared a long-standing relationship; Ardena has now becomes a shareholder in Nanologica.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !